- Price
Supplier Type
- Trader
- Manufacturer
- custom synthesis
- contract manufacturer
- Reagent
Supplier Region
- Hyderabad(2)
- Gujarat(1)
- Maharashtra(1)
- New Delhi(1)
- Himachal Pradesh(1)
Purity
- United States Pharmacopeia (USP) Reference Standard
- recombinant, expressed in E. coli, ≥70% (SDS-PAGE)
- PEG average Mn 10.000
- Non-ionic, 1313 ppm, liquid, cloud point 76 °C
- NLT 90.00%
- Mw 6,000
- Mw 3,000
- Mw 20,000
- Mw 2,000
- Mw 10,000
- mol wt 3350, 0.2 μm filtered
- Mn ~1,500
- liquid, ≥98% (GC)
- Liquid, 800 ppm, cloud point 36 °C
- for synthesis
- BioXtra, ≥98.0% (GC)
- BioXtra, ≥97.0% (GC)
- BioUltra, 500
- average mol wt 350
- average Mn 950, contains 100?ppm MEHQ as inhibitor, 300?ppm BHT as inhibitor
- average Mn 900
- average Mn 750, contains 900-1100?ppm MEHQ as inhibitor
- average Mn 750
- average Mn 700
- average Mn 600
- average Mn 6,000, contains 1000?ppm 4-methoxyphenol as inhibitor
- average Mn 6,000, contains ≤1500?ppm MEHQ as inhibitor
- average Mn 6,000
- average Mn 575
- average Mn 550, contains 80-120?ppm MEHQ as inhibitor, 270-330?ppm BHT as inhibitor
- average Mn 550
- average Mn 500, contains 100?ppm MEHQ as inhibitor, 200?ppm BHT as inhibitor
- average Mn 5,000, PDI ≤1.1
- average Mn 5,000
- average Mn 480, contains 100?ppm MEHQ as inhibitor, 100?ppm BHT as inhibitor
- average Mn 400
- average Mn 4,000, contains MEHQ as inhibitor
- average Mn 4,000, contains ≤300?ppm monomethyl ether hydroquinone as inhibitor
- average Mn 3400, contains MEHQ as inhibitor
- average Mn 3400
- average Mn 300, contains 300?ppm BHT as inhibitor, 100?ppm MEHQ as inhibitor
- average Mn 3,000
- average Mn 250
- average Mn 2000, contains ~1000?ppm MeHQ as stabilizer
- average Mn 20,000, contains MEHQ as inhibitor
- average Mn 20,000, contains ≤1000?ppm MEHQ as inhibitor
- average Mn 20,000 (NMR), PDI ≤1.3
- average Mn 20,000
- average Mn 2,000, contains MEHQ as inhibitor
- average Mn 2,000, contains ≤1500?ppm MEHQ as inhibitor (may contain)
- average Mn 2,000, 50?wt. % in H2O
- average Mn 2,000
- average Mn 10,000, PDI ≤1.2
- average Mn 10,000, contains MEHQ as inhibitor
- average Mn 10,000
- average Mn 1,000, contains MEHQ as inhibitor
- average Mn ~914
- average Mn ~650
- average Mn ~500, contains 100?ppm BHT as stabilizer
- average Mn ~250
- average Mn ~2,000
- average Mn ~1,000
- Avanti Polar Lipids 880224P, powder
- Avanti Polar Lipids 880132P, powder
- Avanti Polar Lipids 880129P, powder
- Avanti Polar Lipids 880129C
- Avanti Polar Lipids 880128C
- Avanti Polar Lipids 880126P, powder
- Avanti Polar Lipids 880126C
- Avanti Polar Lipids 880124X
- Avanti Polar Lipids 880124P, powder
- Avanti Polar Lipids 880123X
- Avanti Polar Lipids 880123P, powder
- Avanti Polar Lipids 880121P, powder
- Avanti Polar Lipids
- ≥ 99.5%
- >99%
- 98%
- > 98%
- >97.0%(GC)
- >96.0%(GC)
- >95% (HPLC)
- ≥95%
- ≥90% (NMR), 5,000
- ≥80%
- 750
- 5,000, ≥90%
- 20,000
- 10,000
- (stabilised) for synthesis
Package
- 4μg
- 500μg
- 1mg
- 5mg
- 10mg
- 25MG
- 50mg
- 100mg
- 250mg
- 500mg
- 1000mg
- 1g
- 1mL
- 5mL
- 5g
- 10g
- 25G
- 25gm
- 50gm
- 50mL
- 50g
- 100gm
- 100g
- 100mL
- 200gm
- 250gm
- 250g
- 250mL
- 500G
- 500gm
- 500mL
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 1MT
- 18%
- 50 gms
- 100 gms
- 500gms
Polyethylene glycol Divinyl ether, Mn: 10000 50856-26-3
Polyglactin 910 Braided & Coated Fast Absorbable Surgical Suture USP (Synthetic) 34346-01-5
Pentaethylene glycol monodecyl ether 23244-49-7
Methoxy peg maleimide 95% 99126-64-4
Methyl-PEG8-NHS Ester 756525-90-3
Polyethylene glycol monomethylether, 350 9004-74-4
Polyethyleneglycol monomethyl ether 9004-74-4
Polyethylene glycol monomethyl ether 2000 9004-74-4





